BTG PLC
Stock Exchange Other OTC
EPS
$0.06
Market Cap
$4.06 B
Shares Outstanding
387.11 M
Public Float
-
BTG PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
387.11 M
Public Float
-
BTG PLC
Stock Exchange London Stock Exchange
EPS
GBP5.02
Market Cap
GBP3.25 B
Shares Outstanding
387.11 M
Public Float
340.38 M

Profile

Address
5 Fleet Place
London London & South East EC4M 7RD
United Kingdom
Employees -
Website http://btgplc.com
Updated 07/08/2019
BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins.

Financials

View All
Created with Highcharts 5.0.14BTG PLCNet Income. Fiscal year is April-March. All values GBP Thousands.24 30024 30033 60033 60060 50060 50033 60033 60015 00015 00020142015201620172018020k40k60k80k
Created with Highcharts 5.0.14BTG PLCSales/Revenue. Fiscal year is April-March. All values GBP Thousands.290 500290 500367 800367 800447 500447 500570 500570 500620 500620 500201420152016201720180200k400k600k800k

Garry Watts
Chairman
Pamela Louise Dame Makin
Chief Executive Officer & Executive Director